Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhibitor of fibroblast growth factor receptor 2 (FGFR2), which is in a first-in-human clinical trial for patients with advanced or metastatic FGFR2-altered solid tumors; RLY-2608, a lead mutant-PI3Ka inhibitor program that targets phosphoinostide 3 kinase alpha; and RLY-1971, an oral small molecule inhibitor of protein tyrosine phosphatase Src homology region 2 domain-containing phosphatase-2 that is in Phase 1 trial in patients with advanced solid tumors. It has collaboration and license agreements with D. E. Shaw Research, LLC to research certain biological targets through the use of D. E. Shaw Research computational modeling capabilities focused on analysis of protein motion to develop and commercialize compounds and products directed to such targets; and Genentech, Inc. for the development and commercialization of RLY-1971. The company was formerly known as Allostery, Inc. and changed its name to Relay Therapeutics, Inc. in December 2015. Relay Therapeutics, Inc. was incorporated in 2015 and is headquartered in Cambridge, Massachusetts. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of Relay Therapeutics Inc..
Relay Therapeutics Inc. business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of Relay Therapeutics Inc. are also analyzed.
Detailed SWOT Analysis of the company including key strengths and weaknesses of Relay Therapeutics Inc. , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed.
Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided.
Financial analysis of Relay Therapeutics Inc. including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of Relay Therapeutics Inc. and all latest updates of the company are provided.
The 2025 version of Relay Therapeutics Inc. report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.
TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 Introduction to the Company
2.1 Relay Therapeutics Inc.- Key Facts
2.2 Relay Therapeutics Inc.- Geographic Locations
2.3 Relay Therapeutics Inc.- Subsidiaries and Affiliates
2.4 Relay Therapeutics Inc.- Business Divisions
2.5 Relay Therapeutics Inc.- Key Employees
2.5.1 Management Team
2.5.2 Board of Directors
3. Relay Therapeutics Inc. Strategic Analysis Review
3.1 Relay Therapeutics Inc.- Key Strategies
3.2 Relay Therapeutics Inc.- Company Outlook Statement
3.3 Relay Therapeutics Inc.- SWOT Analysis
3.3.1 Relay Therapeutics Inc.- Key Strengths
3.3.2 Relay Therapeutics Inc.- Key Weaknesses
3.3.3 Relay Therapeutics Inc.- Potential Opportunities
3.3.4 Relay Therapeutics Inc.- Potential Threats
3.4 Relay Therapeutics Inc.- Key Competitors
4. Business Description of the Company
4.1 Relay Therapeutics Inc.- Business Overview
4.2 Relay Therapeutics Inc.- Operations by Segment
5 Products and Services Details
5.1 Relay Therapeutics Inc.- Key Products
5.2 Relay Therapeutics Inc.- Key Service Areas
5.3 Relay Therapeutics Inc.- Key Brands
6 Company Developments
6.1 Relay Therapeutics Inc.- Company History
6.2 Relay Therapeutics Inc.- Latest Developments
7 Financial Analysis
7.1 Relay Therapeutics Inc.- Income Statements
7.2 Relay Therapeutics Inc.- Balance Sheet
7.3 Relay Therapeutics Inc.- Cash Flow Statements
8 Competitors and Industry Analysis
8.1 Relay Therapeutics Inc.- Direct Competitors
8.2 Relay Therapeutics Inc.- Competitor Financial Ratios comparison
8.3 Relay Therapeutics Inc.- Competitor Stock Charts Comparison
8.4 Relay Therapeutics Inc.- Industry Analysis
9 Appendix
9.1 About SWOTreports
9.2 Sources and Methodology
9.3 Contact Information
P.S.Financial Analysis will be provided only for companies reporting financial data.
Get Free Sample
At SWOT Reports, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Why Request a Free Sample?
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from SWOT Reports. Experience the caliber of insights that can transform the way you approach your business challenges.
FAQ's
Gain valuable insights into the company for academic or business research purposes with this comprehensive profile. Key elements, such as SWOT analysis and corporate strategy, are included to support your research needs effectively.
Customer and Supplier Identification: Analyze the company’s business structure, operations, major products, services, and strategies to identify potential customers and suppliers.
Leverage a detailed SWOT analysis to understand and evaluate your competitors' business structures, strategies, and core performance metrics. This analysis offers an up-to-date and objective perspective on the company’s strengths, weaknesses, opportunities, and threats.
$50- 50%
$100- 15%
$200- 10%
$100- 20%
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!
Reach Out to Us
Industries
Resources
Company
Sign up for Offers & Promotions
- Connect with us
- +91 630 95 25755
- sales@swotreports.com
-
Chat on WhatsApp
